Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05658796 · ClinicalTrials.gov registry record · NA
RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty
A NA study of Depression and Anxiety, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 3
- Study locations
NCT05658796: Recruiting NA study of Depression and Anxiety, sponsored by University of Pittsburgh.
NCT05658796 is a NA study of Depression and Anxiety that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 150 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05658796, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-operative outcomes, improving saving for the UPMC ISD by hastening the recovery and decreased resource utilization, and addition to the high-value care of UPMC with this holistic approach to patient perioperative care
Primary Outcome
This outcome will be measured by extracting pain medication data from the electronic health record to determine OME (oral morphine equivalents) (mg) for opioid medications on POD 1 and 2, and weeks 1 and 4 following surgery. This will be recorded for each study arm as mean (SD).
Conditions Studied
Interventions
- BEHAVIORAL +RxWell
- BEHAVIORAL -RxWell
Study Locations (3)
Pennsylvania
- UPMC East - Monroeville
- UPMC Shadyside - Pittsburgh
- UPMC Passavant - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-01-27 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What NCT05658796 shows while recruiting
NCT05658796 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower).
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which +RxWell is the first listed.
NCT05658796 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05658796 about?
NCT05658796 is a clinical study titled "RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty". It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-ope...
What is the current status of trial NCT05658796?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-01-27. Estimated completion is 2026-12-30.
What conditions does trial NCT05658796 study?
This clinical trial studies the following conditions: Depression, Anxiety, Anxiety Disorders, Depressive Symptoms, Mood Disorders.
What interventions are being tested in trial NCT05658796?
The interventions under investigation include: +RxWell (BEHAVIORAL), -RxWell (BEHAVIORAL).
Who is sponsoring clinical trial NCT05658796?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05658796 being conducted?
This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05658796's enrollment target sits among peer trials
150 249th of 679 higher than 416 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy